Nitric oxide gel as well as preparation method and application thereof
The temperature-sensitive hydrogel carrier NO@CP prepared by mixing chitosan and β-phosphate glycerol, combined with the antibacterial effect of chitosan, solves the drug resistance and side effects of fungal skin infection, and realizes the dual role of Trichophyton red Inhibition and wound healing promote, and have good biocompatibility and degradability.
Patent Information
- Application Number
- CN202410981500.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-19
AI Technical Summary
In the prior art, methods for treating fungal skin infections have problems with drug resistance and side effects. Traditional dressings cannot effectively keep the wound dry and prevent fungal infections, and it is difficult to control the release rate of nitric oxide.
The temperature-sensitive hydrogel carrier NO@CP was prepared by mixing chitosan and β-phosphoric glycerol. It was loaded with nitric oxide. The release rate was regulated by temperature, and combined with the antibacterial effect of chitosan, a synergistic and efficient antibacterial hydrogel was prepared. .
The dual inhibition of Trichophyton red is achieved, which promotes wound healing, shortens the treatment cycle, reduces the inflammatory response, and has good biocompatibility and biodegradability, avoiding the toxic side effects of traditional antifungal drugs.
Smart Images

Figure CN118976141A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of gel, and in particular to nitric oxide gel and a preparation method and application thereof. Background Art
[0002] Superficial fungal disease refers to the infection of skin and soft tissues caused by fungi invading superficial parts of human skin, nails, etc., mostly caused by dermatophytes or yeast infections such as Trichophyton rubrum. The global incidence of superficial fungal disease can reach 20%-25%. In recent years, due to the gradual increase in the number of patients with diabetes, organ transplantation, and AIDS, and the abuse of broad-spectrum antibiotics and immunosuppressants, the incidence of superficial fungal disease has increased year by year. Its high incidence and easy recurrence have placed a heavy burden on society and personal medical insurance.
[0003] Treatments for fungal skin infections usually include topical antifungal drugs, such as terbinafine cream, miconazole nitrate cream, etc., and oral antifungal drugs. However, fungal resistance to antifungal drugs is increasing over time, making some fungal skin infections difficult to treat. Therefore, it is crucial to develop a drug delivery system that is safe and can effectively improve drug utilization.
[0004] In the prior art, topical antifungal drugs are mainly used to treat Trichophyton rubrum infection, but there are problems of drug resistance and side effects. Nitric oxide (NO) has a broad-spectrum antibacterial activity, but the direct application of NO gas has problems such as high volatility and difficulty in controlling the release rate. Loading NO in a suitable carrier to achieve sustained release is the current research direction.
[0005] Traditional wound dressings include gauze, polymer bandages, and cotton wool, which usually only have a simple isolation and protection function. Since the exudate from the wound adheres to the tissue, it is impossible to ensure that the wound bed is dry and avoid fungal infection. In addition, the local dryness caused by traditional dressings makes it difficult for new epithelial cells to migrate, and the debris on the dressing may be blocked in the tissue, causing an inflammatory response. To further promote wound healing, much work is currently focused on delivering growth factors or therapeutic stem cells through dressings, however, these methods are often complicated by drug-related side effects and high costs.
[0006] Hydrogels are a class of highly hydrophilic three-dimensional network structured gels. In recent years, they have been considered as effective candidates for promoting wound healing due to their high water content and stability, as well as their ability to absorb skin exudates and maintain a moist healing environment. The use of inherently antibacterial cationic polymers, including chitosan (CS), quaternary ammonium chitosan (QAS-CS), and cationic peptides, is a feasible and effective approach to developing effective antibacterial hydrogels. CS, as an aminopolysaccharide natural biodegradable cationic polymer, has the advantages of excellent biocompatibility, biodegradability, antibacterial activity, and low cost, and has been widely used in the field of hydrogel wound dressing applications.
[0007] For example, some scholars prepared a series of nanocomposite hydrogel bandages based on CS or chitin, proving that cationic CS interacts with negatively charged blood cells, activates platelets and promotes coagulation. Subsequently, some scholars prepared CS / gelatin / PVA composite hydrogels and further elaborated on the hemostatic mechanism of activated platelets to produce coagulation factors and hydrogel physical sealing. Further studies have shown that transplanting positively charged components onto hydrogels can improve the interaction between hydrogels and platelets, blood cells, and plasma fibronectin through electrostatic effects, induce platelet activation and blood cell aggregation, and thus achieve the effect of promoting coagulation.
[0008] However, CS also has some disadvantages, including poor mechanical strength, low solubility in common dilute acidic solutions, and difficulty in degradation. Therefore, it usually has to be used in combination with other polymers or inorganic agents. Summary of the invention
[0009] In order to comprehensively solve the above problems, the present invention proposes nitric oxide gel and its preparation method and application, and prepares a new type of thermosensitive hydrogel carrier NO@CP, which is prepared by mixing chitosan and β-phosphoglycerol. This hydrogel undergoes a phase transition at 37°C, from a solution to a gel, and its temperature-sensitive properties make it suitable for the skin surface. The NO release rate in the NO@CP hydrogel can be regulated by temperature, realizing intelligent control of the NO release rate, so that it can adapt to the needs of different wound infection levels.
[0010] In order to achieve the above objectives, the first aspect of the present invention provides nitric oxide gel, PEI-NONOate is synthesized using PEI-600 and nitric oxide gas as raw materials, PEI-NONOate is dissolved in β-GP solution, and NO@CP hydrogel loaded with NO is prepared.
[0011] The second aspect of the present invention provides a method for preparing nitric oxide gel, comprising:
[0012] Step 1: Add PEI-600 and nitric oxide gas into a high-pressure reactor and react under high pressure for 72 hours to synthesize PEI-NONOate;
[0013] Step 2: Dissolve β-GP in deionized water to prepare a β-GP solution, add the β-GP solution to the chitosan solution, stir well and place in a constant temperature water bath to form a CS / β-GP hydrogel, which is recorded as CP;
[0014] Step 3: Dissolve the PEI-NONOate prepared in step 1 in the β-GP solution prepared in step 2 to prepare the NO-loaded hydrogel NO@CP.
[0015] Preferably, step 1 comprises:
[0016] Step 1.1: Weigh PEI-600 and dissolve it in anhydrous methanol, and add sodium methoxide to adjust the pH of the solution to alkaline;
[0017] Step 1.2: After transferring the solution of step 1.1 to the autoclave, nitrogen gas was used to purge for five minutes to exhaust the air in the autoclave;
[0018] Step 1.3: Nitric oxide gas was introduced into the autoclave of step 1.2, and the pressure in the autoclave was maintained at 80 Psi. After reacting for 72 hours, the PEI-600 loaded with ionic NO was obtained by precipitation with ether and drying.
[0019] Preferably, the amount of each substance added in step 1.1 is 0.5 g PEI-600, 10 mL anhydrous methanol and 200 μg sodium methoxide.
[0020] Preferably, step 2 comprises:
[0021] Step 2.1: Add chitosan to the glacial acetic acid solution, stir until the chitosan is completely dissolved, and store in a refrigerator at 4°C;
[0022] Step 2.2: Dissolve β-GP in deionized water at 4°C to prepare β-GP solution.
[0023] Preferably, step 3 is specifically:
[0024] PEI-NONOate was dissolved in β-GP solution, mixed with chitosan solution at 4°C, and placed in a constant temperature water bath at 37°C to prepare NO-loaded hydrogel NO@CP.
[0025] A third aspect of the present invention provides a nitric oxide gel for use in preparing a dressing for treating Trichophyton rubrum infection.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] 1. This invention prepares a new type of thermosensitive hydrogel carrier NO@CP for the first time, which is prepared by mixing chitosan and β-phosphoglycerol. This hydrogel undergoes a phase transition at 37°C, from a solution to a gel, and its temperature-sensitive properties make it suitable for the skin surface. The NO release rate in the NO@CP hydrogel can be regulated by temperature, realizing intelligent control of the NO release rate, so that it can adapt to the needs of different wound infection levels.
[0028] 2. The present invention loads NO on polyethyleneimine (PEI) and realizes uniform loading of NO in the hydrogel in the form of PEI-NONOate. This loading method makes the release of NO in the hydrogel more stable and controllable.
[0029] 3. The NO@CP hydrogel prepared by the present invention has synergistic and efficient anti-Trichophyton rubrum activity: by utilizing the synergistic antibacterial effect of NO and chitosan, dual inhibition of Trichophyton rubrum is achieved, thereby overcoming the fungus's resistance to a single antifungal drug and improving the antifungal effect.
[0030] 4. The NO@CP hydrogel prepared by the present invention has multifunctional integration: it can promote the healing of wounds infected with Trichophyton rubrum and shorten the treatment cycle. The results of in vivo experiments showed that the wound healing speed of the NO@CP group was significantly faster than that of the control group, and the formation of new blood vessels was more abundant. The NO@CP hydrogel not only has antibacterial function, but also has multiple functions such as promoting wound healing and inhibiting inflammatory response, providing an integrated solution for the treatment of Trichophyton rubrum infection.
[0031] 5. The NO@CP hydrogel prepared by the present invention has the effect of inhibiting inflammatory response: it can inhibit the inflammatory response caused by Trichophyton rubrum infection, reduce the expression of proinflammatory factors, and promote the production of anti-inflammatory factors (NO@CP hydrogel inhibits inflammatory response through multiple mechanisms, including promoting the transformation of macrophages into anti-inflammatory M2 macrophages, reducing the expression of proinflammatory factors, promoting collagen production and promoting angiogenesis. These mechanisms work together to effectively inhibit wound inflammatory response and accelerate the wound healing process).
[0032] 6. The NO@CP hydrogel prepared by the present invention has good biocompatibility, is non-toxic to 3T3 cells, does not damage the main organs of rats, and is non-toxic to normal cells. It avoids the toxic side effects that may be caused by traditional antifungal drugs and provides a basis for its clinical application.
[0033] 7. The NO@CP hydrogel prepared by the present invention is biodegradable and can be absorbed by the body during the wound healing process (no visible damage, heteromorphic components or toxic side effects were found in the wound tissue of the NO@CP group), avoiding the trouble of removing dressings.
[0034] 8. The preparation process of the NO@CP hydrogel prepared by the present invention is simple, easy to mass produce, reduces the production cost, and is conducive to large-scale application.
[0035] 9. The NO@CP hydrogel prepared by the present invention is suitable for treating Trichophyton rubrum infections, including superficial infections and deep infections.
[0036] 10. The NO@CP hydrogel prepared by the present invention can be directly applied to the wound surface, is easy to use, and does not require professional medical staff to operate. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] The accompanying drawings are used to provide further understanding of the present invention and constitute a part of the specification. They are used to explain the present invention together with the embodiments of the present invention and do not constitute a limitation of the present invention.
[0038] In the attached picture:
[0039] Figure 1 Synthesis and characterization of NO@CP: Figure 1 (A) Schematic diagram of the synthesis of NO@CP. Figure 1 (B) CS / β-GP gel at 4°C; Figure 1 (C) CS / β-GP gel at 37°C; Figure 1 (D) and Figure 1 (E) TEM images of NO@CP1 and NO@CP2, respectively; Figure 1 (F) Gelation time of different ratios of CS and β-GP; Figure 1 (G) and Figure 1 (H) Rheological images of NO@CP gel at different times and temperatures; Figure 1 (I) is the UV spectrum of NO@CP after reacting with Griess reagent; Figure 1 (J) is the swelling ratio of NO@CP; Figure 1 (K) is the NO@CP slow release curve.
[0040] Figure 2 Research on the antibacterial properties of NO@CP: Figure 2 (A) The amount of residual fungi after treatment with different materials; Figure 2 (B) Antibacterial rate of Trichophyton rubrum in suspension after treatment with different materials.
[0041] Figure 3 (A) Images of the rats’ status and wound area changes on different days after receiving different treatments; Figure 3 (B) Comparison of wound areas on different days after different treatments in rats infected with Trichophyton rubrum; Figure 3 (C) The number of fungi remaining in the wound on the 10th day after different treatments; Figure 3(D) Relative survival numbers of Trichophyton rubrum in different groups on day 10.
[0042] Figure 4 (A) H&E and Masson-stained histological images of wound tissue collected on day 10, scale bar = 60 μm; Figure 4 (B) Quantitative analysis of collagen deposition in rats infected with Trichophyton rubrum; Figure 4 (C) Quantitative analysis of IL-1β in rats infected with Trichophyton rubrum; Figure 4 (D) Quantitative analysis of TNF-α in rats infected with Trichophyton rubrum.
[0043] Figure 5 (A) Double immunofluorescence labeling of CD31 (red) and α-SMA (green) on day 10, scale bar = 50 μm; Figure 5 (B) is a quantitative assessment of CD31 coverage on day 10 of T. rubrum infection; Figure 5 (C) Doppler imaging analysis of the wound healing progress in rats on day 10.
[0044] Figure 6 (A) is the survival rate of 3T3 cells under different treatments; Figure 6 (B) H&E staining images of the heart, liver, spleen, lung, and kidney of rats after 10 days of treatment; scale bar = 100 μm.
[0045] Figure 7 The present invention is a flow chart of the method for preparing nitric oxide gel. DETAILED DESCRIPTION
[0046] The following combination Figure 1-Figure 7 The preferred embodiments of the present invention are described. It should be understood that the preferred embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0047] Embodiment 1:
[0048] Nitric oxide gel, PEI-NONOate was synthesized using PEI-600 and nitric oxide gas as raw materials, and PEI-NONOate was dissolved in β-GP solution to prepare NO-loaded hydrogel NO@CP.
[0049] Embodiment 2:
[0050] A method for preparing nitric oxide gel, comprising:
[0051] Step 1: Add PEI-600 and nitric oxide gas into a high-pressure reactor and react under high pressure for 72 hours to synthesize PEI-NONOate. Including:
[0052] Step 1.1: Weigh 0.5 g of PEI-600 (polyethyleneimine, 600 in PEI-600 represents the relative molecular mass of polyethyleneimine, that is, the average molecular weight of each PEI molecular chain is about 600) and dissolve it in 10 mL of anhydrous methanol, and add 200 μg of sodium methoxide to adjust the pH of the solution to between 14 and 15;
[0053] Step 1.2: After transferring the solution of step 1.1 to the autoclave, nitrogen gas was used to purge for five minutes to exhaust the air in the autoclave;
[0054] Step 1.3: Nitric oxide gas was introduced into the autoclave of step 1.2, and the pressure in the autoclave was maintained at 80 Psi. After reacting for 72 hours, the mixture was precipitated with ether and dried to obtain PEI-600 loaded with ionic NO, namely PEI-NONOate.
[0055] PEI-NONOate contains two NOs because the amino group on the PEI molecular chain can react with two nitro compounds to form two nitro-substituted compounds, namely PEI-NONOate.
[0056] At means "acid radical" or "substituent". Here, NO is a nitro compound, which replaces the amino group on the PEI molecular chain through chemical reaction to form PEI-NONOate.
[0057] Step 2: Dissolve β-GP (β-phosphoglycerol) in deionized water to prepare β-GP solution, add the β-GP solution to the chitosan solution, stir and mix thoroughly, and place in a constant temperature water bath to form CS / β-GP hydrogel, which is recorded as CP. Including:
[0058] Step 2.1: Add 5 g of chitosan to 200 mL of 0.1 M glacial acetic acid solution, stir until the chitosan is completely dissolved, and store in a refrigerator at 4 °C;
[0059] Step 2.2: Dissolve β-GP in deionized water at 4°C to prepare β-GP solutions with different mass concentrations (20%, 30%, 40%);
[0060] Step 2.3: Under stirring conditions at 0°C, add 0.3 mL of β-GP solution to 0.1 mL of chitosan solution, stir thoroughly to mix, and place in a constant temperature water bath at 37°C. Determine the time for gel formation by timing, and finally obtain CS / β-GP hydrogel, recorded as CP.
[0061] Step 3: Dissolve the PEI-NONOate in step 1 in the β-GP solution in step 2 to obtain the NO-loaded hydrogel NO@CP. Specifically:
[0062] 3 mg of PEI-NONOate was dissolved in 20%, 30%, or 40% β-GP solution, mixed with 2.5% chitosan solution at 4°C, and placed in a constant temperature water bath at 37°C to prepare NO-loaded hydrogel NO@CP.
[0063] The hydrogel NO@CP undergoes a phase transition at 37°C, and the CS / β-GP gel has good biocompatibility and biodegradability. The CS / β-GP hydrogel is mainly prepared by mixing the dissolved chitosan with the β-GP solution with NO added at low temperature, and then the temperature rises to room temperature, and the entire solution undergoes obvious gelation behavior. At the same time, NO is evenly dispersed inside the hydrogel, and finally a thermosensitive polymer hydrogel NO@CP with high efficiency antibacterial, biofilm dissipation, and wound healing promotion is obtained.
[0064] The gelation temperature of CP hydrogel is 37°C (optimal body temperature), which makes CP hydrogel an ideal material for covering the skin surface and exerting antibacterial effects.
[0065] The present invention loads NO on polyethyleneimine (PEI) and realizes uniform loading of NO in the hydrogel in the form of PEI-NONOate. The reasons are as follows:
[0066] PEI-NONOate can be uniformly loaded in the hydrogel, mainly due to the following factors:
[0067] 1. Characteristics of PEI molecules:
[0068] Cationicity: PEI has positive charges on its molecular chain, which can interact with negatively charged hydrogel matrices (such as chitosan) through electrostatic interactions, thereby being evenly distributed in the matrix.
[0069] Water solubility: PEI molecules have good water solubility and can interact with water molecules in the hydrogel, thereby being better dispersed in the gel.
[0070] 2. Preparation process of NO@CP hydrogel:
[0071] Low temperature mixing: When preparing NO@CP hydrogel, PEI-NONOate is first dissolved in β-GP solution and then mixed with chitosan solution under low temperature conditions. Low temperature can slow down the interaction between PEI-NONOate and chitosan, thereby avoiding local aggregation and ensuring uniform distribution.
[0072] Slow heating: The mixed solution gradually gels during the slow heating process, and PEI-NONOate is evenly wrapped in the hydrogel network during the gelation process.
[0073] 3. Structure of hydrogel:
[0074] Porous structure: NO@CP hydrogel has a porous structure that can accommodate PEI-NONOate molecules and ensure their uniform distribution.
[0075] Flexibility: The hydrogel has a certain flexibility, which can prevent the PEI-NONOate molecules from aggregating due to mechanical stress.
[0076] Summarize:
[0077] The uniform loading of PEI-NONOate in NO@CP hydrogel is due to the combined effects of the properties of PEI molecules, the preparation process, and the hydrogel structure. This uniform loading method ensures the stable and controllable release of NO in the hydrogel, thereby improving its antibacterial and wound healing effects.
[0078] Embodiment 3:
[0079] The nitric oxide gel prepared by the invention is used for preparing a dressing for treating trichophyton rubrum infection.
[0080] test:
[0081] 1 Characterization of thermosensitive polymer hydrogel NO@CP
[0082] UV-Vis-NIR spectra of the samples were recorded on a UV-3600 Plus (Shimadzu) spectrophotometer. The structure of the liposome nanoparticles was measured using Fourier transform infrared (FTIR) using a VERTX 70 FTIR (Bruker Dalton, Germany) in transmittance mode with KBr particles. The rheological properties of the hydrogels were evaluated using a rheometer. The surface morphology of the hydrogels was obtained using a scanning electron microscope.
[0083] 1.1 Swelling rate of hydrogel
[0084] The equilibrium swelling ratio (ESR) of the hydrogel was determined by a swelling test. In short, the fully gelled wet hydrogel was immersed in 20 mL of phosphate buffered saline (PBS, 0.1 M, pH = 7.4) at 37 ° C. After removing the surface water using filter paper at a preset time, the hydrogel sample was picked out and weighed. The weight was recorded before reaching equilibrium. The ESR of the hydrogel was calculated using the equation.
[0085] All tests were repeated three times.
[0086]
[0087] w trepresents the weight of the hydrogel after swelling for a preset time, and w0 represents the weight of the hydrogel before swelling.
[0088] 1.2 SEM images of hydrogels
[0089] The blank hydrogel CP and the NO-loaded hydrogel NO@CP were first frozen in a -80°C refrigerator overnight and then placed in a freeze dryer. The dry gel was placed on the SEM stage, sputtered with gold, and then placed in the machine to observe its surface morphology.
[0090] 1.3 Fourier near infrared spectroscopy (FTIR) characterization
[0091] Wipe all experimental equipment such as the agate dish with alcohol and dry them thoroughly. Weigh about 120 mg of fully dried potassium bromide (HBr) and place it in the agate dish and grind it into powder. Then take appropriate amounts of PEI-NONOate, CP and NOCP powders and mix them with it. Continue to grind it into fine powder, use a tablet press to press it into a transparent sheet with a thickness of less than 1 mm, and then use a Fourier transform infrared spectrometer in transmission mode for testing. Among them, blank KBr is used as the background, the test wave number range is 4000-500cm-1, and the resolution is 4cm-1.
[0092] 1.4 Ultraviolet spectroscopy characterization (UV-vis)
[0093] 400uL of CP and NO@CP hydrogels were soaked in 10mL of deionized water respectively. After soaking for 4h, 1mL of hydrogel extract was taken out and placed in a quartz dish, and the absorbance of the solution was detected at 200-800nm.
[0094] 1.5 Rheological characterization
[0095] In this experiment, a rotational rheometer was used to test the rheological properties of the hydrogel. First, about 320 μL of hydrogel was placed on the test plate of the rotational rheometer, the bottom plate temperature was set to 10°C, and a 20 mm diameter flat plate was selected as the top fixture for measurement in dynamic oscillation mode. In the dynamic temperature scan, the strain was selected to be 5%, so that the strain was in the linear viscoelastic region, ensuring that the storage modulus G' and loss modulus G" were independent of the strain amplitude, the frequency was set to 10 rad / s, and the temperature was increased from 10°C to 45°C at a rate of 1.5°C / min. For the time scan sequence, the bottom plate temperature was set to 37°C. After fully preheating to a stable temperature, the hydrogel was added and allowed to stand for 30s. The scan time was set to 600s, and the remaining conditions were the same as the dynamic temperature scan, and then the test was carried out.
[0096] 2 In vitro experiments
[0097] 2.1 Fungal culture
[0098] The clean workbench and materials were disinfected with ultraviolet light. Everything on the clean bench was disinfected with 75% alcohol. Before fungal culture, the culture medium, culture dishes and other containers were sterilized. The Trichophyton rubrum strain was obtained from the Guangdong Microbial Culture Collection Center and cultured according to the standard. After the Trichophyton rubrum inoculated on SDA agar medium was cultured in a constant temperature incubator at 28°C for 7 days, a single colony was taken with an inoculation loop, fresh SDB medium was added and cultured in a shaker at 28°C for 7 days, and the concentration of the bacterial suspension was adjusted to 1×108CFU / mL for use.
[0099] 2.2 Antibacterial test
[0100] Trichophyton rubrum at a concentration of 1×108 CFU / mL was treated with Control, CP, NO@CP-1, NO@CP-2, and NO@CP-3, respectively. After co-culture in a shaking incubator at 28°C for 4 hours, the co-culture solution was diluted in a gradient manner. The diluted solution was then spread on sterile SDA agar medium and cultured in an incubator at 28°C for 7 days. Finally, the number of colonies was counted to evaluate the antibacterial properties of NO@CP.
[0101] 3 Animal experiments
[0102] 3.1 Fungal infection wound modeling
[0103] Male SD rats (average weight 200 g) were purchased from Guangzhou Ruige Biotechnology Co., Ltd. All rats were free of specific pathogens. All animal experiments were approved by the Experimental Animal Management Committee. Male SD rats were divided into 6 groups, 5 in each group. Before the experiment, they were kept in a sterile environment with a natural light-dark cycle for 7 days. After intraperitoneal injection of sodium pentobarbital, the back of the rat was shaved with the spine as the central axis to form a square surgical area. Depilatory cream was used for further depilation. After sterilization, two 10 mm wounds were produced on each rat by dermal excision. Trichophyton rubrum solution (150 μL, 1×107 CFU / mL) was added to each wound. After 2 days, agar plates were used to confirm the successful modeling of fungal infection wounds.
[0104] 3.2 Organizational Analysis
[0105] Paraformaldehyde (Beyotime, 4% (w / v)) was used to fix the healed tissue samples immediately after removal from the back of the rats. The samples were then embedded in paraffin and sliced for subsequent processing (H&E staining, Masson's trichrome staining, immunohistochemistry and vascularization analysis). The obtained samples were observed and analyzed using an optical microscope.
[0106] 4 Biocompatibility analysis
[0107] Rat fibroblasts (3T3) were selected to evaluate the cytocompatibility of NO@CP. Briefly, 3T3 cells were resuspended in DMEM complete culture medium containing 10% FBS and 1% double antibody, seeded in 96-well plates at a density of 1×104 cells per well, and cultured overnight at 37°C in a cell culture incubator with 5% CO2. Afterwards, the culture medium was discarded and fresh complete culture medium containing Control, CP, NO@CP-1, NO@CP-2 and NO@CP-3 was added. Each concentration was repeated 5 times, and fresh culture medium was used as a negative control.
[0108] 5 Statistical analysis
[0109] Each experiment contained at least three parallel samples and was expressed as mean ± SD. The differences between experimental groups were analyzed using GraphPad software. One-way ANOVA test and Tukey post hoc analysis were performed. The significant difference levels were marked as follows: p < 0.05 (*), p < 0.01 (), and p < 0.001 (*).
[0110] Results and Discussion
[0111] 1. Preparation and characterization of thermosensitive polymer hydrogel NO@CP
[0112] Chitosan (CS) is an aminopolysaccharide natural biodegradable cationic polymer that has recently been clinically and experimentally tested in different applications due to its excellent biocompatibility, biodegradability, antimicrobial activity, wound healing ability, and low cost. However, CS also has some disadvantages, including poor mechanical strength, low solubility in common dilute acidic solutions, and difficulty in degradation. Therefore, it usually has to be combined with other polymers or inorganic agents for further improvement.
[0113] CS and β-phosphoglycerol (β-GP) thermosensitive hydrogels can remain in solution at low temperatures, but transform into a network structured solid material at physiological pH and body temperature. At the same time, CS / β-GP gels are biocompatible and biodegradable. CS / β-GP hydrogels are mainly made by mixing dissolved chitosan with β-GP solution with NO added at low temperatures, then raising the temperature to room temperature, and the entire solution undergoes obvious gelation behavior, while NO is also evenly dispersed inside the hydrogel. The entire process is as follows: Figure 1 As shown in A. At 4°C, the mixture of CS / β-GP gel is in a liquid state ( Figure 1 B), when the temperature gradually rises to about 37°C, the color of the gel mixture gradually changes from transparent to opaque, and it does not flow after being inverted ( Figure 1 C), indicating that the gel mixture has undergone obvious phase transition and gelation behavior.
[0114] The gelation temperature of CP hydrogel is 37°C (optimal body temperature), which makes CP hydrogel an ideal material for covering the skin surface and exerting antibacterial effects. CP and NO@CP hydrogels were freeze-dried and the interior of the hydrogels was observed by TEM. Figure 1 As shown in D and E, the interior of the hydrogel presents a dense pore structure, which can improve the sustained release effect of NO and provide favorable conditions for NO to better exert its antibacterial effect. At the same time, after loading NO, the internal pore size did not change significantly. In order to explore the differences between the gelation time and gelation temperature of chitosan solutions with different proportions and β-GP with different concentrations, 2.5% chitosan hydrogel was mixed with different volumes of 30% β-GP solution, placed in a constant temperature water bath at 37°C, and the inversion method was used to determine whether a gel was formed. The results are shown in Figure 1 As shown in Figure F, when the volume ratio of chitosan to β-GP is 1:1, the gelation time is greater than 500s. When the volume ratio is 1:2, the gelation time is 180s, and when the ratio is 1:3, the gelation time is shortened to 120s, and when the volume ratio is 1:4, the gelation time is 60s. The results show that as the concentration of β-GP increases, the gelation time also decreases. The gelation time at a volume ratio of 1:3 was further confirmed by a rotational rheometer, and the results are shown in Figure 3. Figure 1 G and H keep the temperature and frequency constant. As time increases, G" is greater than G', indicating that the viscous modulus is greater than the elastic modulus, and the mixed solution is in a flowing state. When G' is greater than G" at 126s, an obvious phase transition occurs. The elastic modulus of the mixed solution is greater than the viscous modulus, and it is transformed into an elastic solid with a certain viscoelastic state. This time point is the gelation time, which is consistent with the result of the inversion method. The thermosensitive properties of the hydrogel were then tested by changing the temperature of the rotational rheometer. When the temperature reached 36.8℃, G' was greater than G", and the mixed solution turned into a gel state. 36.8℃ is the phase transition temperature of the gel. Considering that β-GP itself has certain cytotoxicity, the volume ratio of 1:3 is selected as the optimal gelation ratio. After binding with NO, the Griess reagent will show an obvious absorption peak at 540nm. In order to verify the successful loading of NO, the extract of the hydrogel was extracted and the Griess reagent was added to observe the change of the absorption peak under the ultraviolet spectrum. The results are as follows Figure 1 As shown in Figure 1, the pure hydrogel has no obvious absorption peak at 540 nm, while the NO@CP loaded with NO has an obvious absorption peak at 540 nm.
[0115] Polymer hydrogels are composed of a network structure of polymers and solvents (usually water), so hydrogels can show significant swelling in water. The swelling rate of the hydrogel measured by the immersion method is about 140%. After adding NO, there is no significant change in the swelling rate of the hydrogel ( Figure 1J). CP hydrogel has dense pores and can effectively release NO. After NO was loaded into the CP hydrogel, it was immersed in PBS and the concentration change of NO in the supernatant was detected using Griess reagent. The results are shown in Figure 1 As shown in Figure K, the half-life of pure PEI-NONOate is about 20 minutes, and within 1 hour, the concentration of NO no longer increases. However, when NO is evenly mixed in the CP hydrogel NO@CP group, the half-life of NO release increases to 3 hours, and there is still a slow release after 12 hours. The hydrogel can effectively release NO slowly and improve the utilization rate of NO.
[0116] 2. Antibacterial properties of thermosensitive polymer hydrogel NO@CP
[0117] In order to more comprehensively reveal the antifungal properties of NO@CP, NO@CP with different ratios was co-cultured with Trichophyton rubrum in the logarithmic phase for 4 h, and then the bacterial solution was diluted and plated for counting to evaluate the killing effect of the material on planktonic fungi.
[0118] The experimental results are as follows Figure 2 As shown in A, compared with the blank group, observation of the agar plate found that a large number of Trichophyton rubrum died after the action of different ratios of NO@CP, among which NO@CP-3 had the lowest fungal survival rate, with Trichophyton rubrum only having a survival rate of about 2.68% and 0%, and the killing of fungi was dependent on the concentration of NO. The fungal survival rates of NO@CP-1 with lower NO content were 48.06% and 42.30%, respectively, and the fungal survival rates of NO@CP-2 were 17.57% and 28.05%, respectively.
[0119] Similarly, compared with the blank group and the CP group, it can be seen that CP has a small amount of killing effect on fungi, which is due to the certain antibacterial effect of chitosan in CP. However, the introduction of NO significantly enhanced the killing effect on the two fungi, and as the NO concentration increased, the amount of fungal residues on the agar plate was significantly reduced, and the sterilization efficiency was improved. This is because the active molecule NO and its byproducts in various oxidized states can cause the inactivation of various enzymes and DNA in Trichophyton rubrum, change the sensitivity of fungi to external stimuli, further affect their cell membranes and genetic information, and prevent fungi from obtaining energy.
[0120] In short, the experimental results showed that the bactericidal effect of NO@CP hydrogel on Trichophyton rubrum was significantly better than that of the blank group and CP group. The bactericidal effect of NO@CP hydrogel increased with the increase of NO concentration. There was a synergistic antibacterial effect between NO and chitosan, which jointly improved the antifungal effect. These results proved that NO@CP hydrogel had synergistic and efficient anti-Trichophyton rubrum activity, and overcame the fungal resistance to a single antifungal drug, thus improving the antifungal effect.
[0121] 3. Thermosensitive polymer hydrogel NO@CP accelerates the treatment of fungal skin infections
[0122] To further investigate whether NO@CP can promote wound healing of fungal infections in vivo, we selected a rat model of Trichophyton rubrum-infected wounds for study. During this process, we recorded the rats' activities, wound healing on different days, and monitored their weight changes in real time. First, we used this strain to induce wounds with a diameter of 10 mm. The model was divided into three groups, namely the Control group, the CP group, and the NO@CP group. Two days after wound induction (day 0), a large area of yellow pus and a small amount of hyphae were found on the created wounds, and these samples were collected on the 5th and 10th days for subsequent fungal quantitative analysis. For the next 10 days, the Control group, the CP group, and the NO@CP group were treated, and the wound area and body weight of the three groups were recorded.
[0123] It can be found that compared with the Control group and the CP group, the wound healing of the NO@CP group was significantly improved, the number of fungal survival was significantly reduced, and the body weight remained basically stable. These results show that NO@CP has significant antibacterial and wound healing effects. At the same time, blood and pathological sections of the rats were collected on the 5th and 10th days of treatment. By analyzing these samples, we further confirmed the antibacterial effect of NO@CP and its ability to promote wound healing.
[0124] In this study, we first performed a detailed analysis of the wound area and fungal counts in the NO@CP group. The results showed that the NO@CP group exhibited a certain effect on wound healing in vivo. This effect was mainly attributed to the pro-angiogenic properties of nitric oxide (NO).
[0125] In addition, since the reduction of fungal populations is believed to be beneficial for wound healing in vivo, NO molecules with antibacterial properties are more advantageous in promoting wound healing. During the treatment, we conducted continuous quantitative analysis of the wound areas of the Control group, CP group, and NO@CP group. After 10 days of treatment, the wound area of the NO@CP group was reduced to 0.35±0.06% compared with the initial state, while the wound area of the CP group was still 5.34±0.35%. This result shows that in the presence of NO, the healing speed of the NO@CP group is faster than that of the other groups.
[0126] The wound healing speed of the NO@CP group was significantly faster than that of the control group, indicating that it can shorten the treatment period. And through the analysis of these samples, we further confirmed the antibacterial effect of NO@CP and its ability to promote wound healing.
[0127] At the same time, we monitored the infection of the wound in real time during the treatment. The results showed that the number of fungi in the wound decreased after the action of NO@CP. After 5 days of continuous treatment, the relative fungal count of NO@CP in the Trichophyton rubrum group decreased to 32.16%, and after 10 days of treatment, the relative fungal count decreased to 0. This result proves that NO has excellent fungal clearance ability. In general, our research results show that NO plays an important role in inhibiting the inflammatory environment of the wound and shortening the wound healing cycle.
[0128] A large number of studies have shown that NO can promote the transformation of macrophages into anti-inflammatory M2 macrophages and effectively reduce the expression of pro-inflammatory factors such as IL-1β and TNF-α. Figure 4 As shown, the results showed that the wounds in the control group and CP group were still distributed with a large amount of IL-1β and TNF-α secretions after treatment, indicating that the wound inflammatory response was obvious, and this result also corresponded to the trend of the relative number of fungi in the wound. In this study, the results of H&E and Masson staining further showed that on the 10th day of treatment, the new stratum corneum of the wound after NO@CP treatment was intact, the connective tissue was neatly arranged, and new granulation tissue and fibroblasts were generated. This is in sharp contrast to the wounds after the action of other materials, in which inflammatory cells such as neutrophils were present in the wounds, and the stratum corneum was over-keratinized. In Masson staining, we observed that a large number of collagen fibers stained blue were found in the NO@CP-treated groups, and these new collagens showed the characteristics of directional arrangement (such as Figure 4 A). Furthermore, by calculating the amount of collagen deposition in the slices, it was found that the amount of collagen deposition in the wound after the action of NO can reach more than 75%. The collagen deposition in the NO@CP group of Trichophyton rubrum reached 88.13±0.94%, while that in the CP group was only 71.91±2.09%. This finding further confirms the positive effect of NO on wound healing. Therefore, the above results prove that when the infection is effectively controlled, the presence of nitric oxide (NO) can effectively accelerate the generation and enrichment of wound collagen, recruit downstream keratinocytes, and promote skin epithelialization and granulation formation. This finding reveals the important role of NO in improving the speed of wound healing.
[0129] The degree of new blood vessel formation in the wound is the key to evaluating wound healing. Immunofluorescence staining of endothelial cell markers (CD31) and fibroblast markers (α-SMA) in the wound after treatment with different materials is an important indicator for evaluating the degree to which the materials promote wound vascularization. Figure 5As shown in A, the new blood vessels in the control group and the CP group were sparsely distributed, indicating a low degree of vascularization. However, the vascular density of the NO@CP group was significantly improved, and the area of CD31-positive cells in the NO@CP group reached 49.58±8.47% on the 5th day of treatment. It reached 14.13±0.75% on the 10th day of treatment (Figure B, Figure C), while the CP group had only 6.65±0.86% and 6.74±0.51%, respectively. The above results show that as the treatment progresses, the wound gradually heals, the expression of CD31 and α-SMA gradually decreases, and under the influence of NO, the fluorescence intensity of α-SMA (red arrow) and CD31 (green arrow) in the wound of the NO@CP group increases most significantly, and the degree of vascularization is the highest. The above results show that the mechanism of NO molecules as endogenous signal molecules to promote wound healing has been fully revealed, showing great clinical application value in the healing of fungal infection wounds. At the same time, the blood flow of rat skin wounds treated with NO@CP was significantly increased compared with CP using laser speckle blood flow imaging. The NO@CP group was 1.88 times that of the CP group, which indicates that NO significantly promoted the development of blood vessels in the wound of rats ( Figure 5 C). This is because NO, as an important messenger molecule that mediates many signal pathways in the human body, participates in the repair and formation of blood vessels, thereby effectively accelerating the healing process of wounds.
[0130] 4. Biosafety Assessment
[0131] Cytotoxicity is one of the important indicators for evaluating the biocompatibility of biomedical materials. In order to explore the in vitro cytotoxicity of NO@CP, this study used 3T3 cells to determine the cell survival rate under different treatments. Figure 6 As shown in Figure A, the cell survival rates of CP and NO@CP have been higher than 90%, which shows that all materials in this study have good cell compatibility. At the same time, with the increase of NO concentration, the survival rate of 3T3 also gradually increased, and NO@CP-3 can even promote the proliferation of 3T3. At the same time, in order to further explore the toxicity of each group of materials on the main organs of mice, the main organs, including heart, liver, spleen, lung and kidney, were collected after the animal treatment for H&E staining analysis. The experimental results are shown in Figure 1. Figure 6 As shown in B, no visible damage or toxicity was found in the mouse organs after the various materials involved in this study, indicating that all the materials involved in this study have good in vivo safety. Therefore, the above results fully demonstrate that NO@CP with good biosafety has the potential value for practical clinical applications.
[0132] The above shows and describes the basic principles, main features and advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments, and the above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention to be protected. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. Nitric oxide gel, characterized in that: PEI-NONOate was synthesized using PEI-600 and nitric oxide gas as raw materials, and PEI-NONOate was dissolved in β-GP solution to prepare NO-loaded hydrogel NO@CP.
2. A method for preparing nitric oxide gel, characterized in that: include Step 1: Add PEI-600 and nitric oxide gas into a high-pressure reactor and react under high pressure for 72 hours to synthesize PEI-NONOate; Step 2: Dissolve β-GP in deionized water to prepare a β-GP solution, add the β-GP solution to the chitosan solution, stir well and place in a constant temperature water bath to form a CS / β-GP hydrogel, which is recorded as CP; Step 3: Dissolve the PEI-NONOate prepared in step 1 in the β-GP solution prepared in step 2 to prepare the NO-loaded hydrogel NO@CP.
3. The method for preparing nitric oxide gel according to claim 2, characterized in that: Step 1 includes: Step 1.1: Weigh PEI-600 and dissolve it in anhydrous methanol, and add sodium methoxide to adjust the pH of the solution to alkaline; Step 1.2: After transferring the solution of step 1.1 to the autoclave, nitrogen gas was used to purge for five minutes to exhaust the air in the autoclave; Step 1.3: Nitric oxide gas was introduced into the autoclave of step 1.2, and the pressure in the autoclave was maintained at 80 Psi. After reacting for 72 hours, the PEI-600 loaded with ionic NO was obtained by precipitation with ether and drying.
4. The method for preparing nitric oxide gel according to claim 3, characterized in that: The amount of each substance added in step 1.1 is 0.5 g PEI-600, 10 mL anhydrous methanol and 200 μg sodium methoxide.
5. The method for preparing nitric oxide gel according to claim 4, characterized in that: Step 2 includes: Step 2.1: Add chitosan to the glacial acetic acid solution, stir until the chitosan is completely dissolved, and store in a refrigerator at 4°C; Step 2.2: Dissolve β-GP in deionized water at 4°C to prepare β-GP solution.
6. The method for preparing nitric oxide gel according to claim 5, characterized in that: Step 3 is as follows: PEI-NONOate was dissolved in β-GP solution, mixed with chitosan solution at 4°C, and placed in a constant temperature water bath at 37°C to prepare NO-loaded hydrogel NO@CP.
7. Use of the nitric oxide gel prepared by the method according to any one of claims 2 to 6 for preparing a dressing for treating Trichophyton rubrum infection.
Citation Information
Cited By
Macromolecular NO donor hydrogel precursor solution for promoting wound healing as well as preparation method and application of macromolecular NO donor hydrogel precursor solution
CN122440557A
